|
CHD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64657176782157E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38793446022601E-12 |
| Normal-vs-Stage2 |
1.228470E-04 |
| Normal-vs-Stage3 |
2.95469981814733E-10 |
| Normal-vs-Stage4 |
4.05979999995587E-06 |
| Stage1-vs-Stage2 |
7.223400E-01 |
| Stage1-vs-Stage3 |
7.975800E-01 |
| Stage1-vs-Stage4 |
2.276300E-02 |
| Stage2-vs-Stage3 |
6.383000E-01 |
| Stage2-vs-Stage4 |
1.183840E-01 |
| Stage3-vs-Stage4 |
5.455800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.52571355128384E-14 |
| Normal-vs-AfricanAmerican |
3.429100E-04 |
| Normal-vs-Asian |
1.382020E-03 |
| Caucasian-vs-AfricanAmerican |
5.961400E-01 |
| Caucasian-vs-Asian |
8.852600E-01 |
| AfricanAmerican-vs-Asian |
9.224200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.21579446299825E-11 |
| Normal-vs-Female |
3.67894603670038E-12 |
| Male-vs-Female |
6.317600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.126100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.11739523084498E-11 |
| Normal-vs-Age(61-80Yrs) |
6.74094113861656E-12 |
| Normal-vs-Age(81-100Yrs) |
1.483000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.538160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.380000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.164410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.903400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.550800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.349600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.958240E-02 |
| Normal-vs-Grade 2 |
8.77076189453874E-15 |
| Normal-vs-Grade 3 |
1.31389998880849E-09 |
| Normal-vs-Grade 4 |
2.842900E-04 |
| Grade 1-vs-Grade 2 |
7.749200E-01 |
| Grade 1-vs-Grade 3 |
2.759000E-01 |
| Grade 1-vs-Grade 4 |
1.941360E-01 |
| Grade 2-vs-Grade 3 |
2.000800E-03 |
| Grade 2-vs-Grade 4 |
2.504600E-03 |
| Grade 3-vs-Grade 4 |
4.066600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
6.28140000014099E-07 |
| ccA subtype-vs-ccB subtype |
2.07969999999058E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72519776242552E-11 |
| Normal-vs-N1 |
5.680300E-02 |
| N0-vs-N1 |
4.830800E-01 |
|
|
